06978 IMMUNOTECH-B
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 0.20X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | N/A | Net Margin | N/A |
Total Debt/Equity | N/A | Return on Equity | N/A |
Price/Book | N/A | Return on Assets | N/A |
(HKD 4.150) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -198.78 | -369.04 | -356.66 | -433.25 | -521.06 |
---|---|---|---|---|---|
Net Profit Growth (%) | +46.1 | -3.5 | +17.7 | +16.9 | -328.4 |
Earnings Per Share (HKD) | -0.386 | -0.717 | -0.693 | -0.842 | -1.174 |
Earnings Per Share Growth (%) | +46.1 | -3.5 | +17.7 | +28.3 | +100.0 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | -0.028 | 0.372 | 1.108 | 1.954 | 2.601 |
Auditors' Opinion | Unqualified # | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Operating Result | -186.378 | -335.675 | -44.5 | -320.459 |
Profit Before Taxation | -186.417 | -335.479 | -44.4 | -321.095 |
Taxation | 0.926 | 0 | N/A | 0 |
Profit /( Loss) After Taxation | -187.343 | -335.479 | -44.2 | -321.095 |
Minority Interests | -0.431 | -0.66 | -34.7 | -2.986 |
Net Profit | -186.912 | -334.819 | -44.2 | -318.109 |
Earnings Per Share () | -0.3863 | -0.7172 | -46.1 | -0.6931 |
Announcement Date | 2025-03-31 | 2024-03-28 | NA | 2023-03-24 |
* Annualised
Last Update Time: 2025-07-22 21:40:25